Patents Assigned to Allergy Immuno Technologies, Inc.
  • Allergen-thymic hormone conjugates for treatment of IgE mediated allergies
    Patent number: 5275814
    Abstract: A protein conjugate or mixture useful in immunotherapy composed of a biological response modifier (BRM) and an allergen is disclosed. In use the protein conjugate or mixture is combined with a pharmaceutically acceptable carrier. Cytokines, bacterial, fungal and viral immunopotentiators and thymus hormones are disclosed as suitable BRM's for use in the invention.
    Type: Grant
    Filed: July 10, 1991
    Date of Patent: January 4, 1994
    Assignee: Allergy Immuno Technologies, Inc.
    Inventor: Aristo Wojdani
  • Immunotherapy agents for treatment of IgE mediated allergies
    Patent number: 5116612
    Abstract: A protein conjugate or mixture useful in immunotherapy composed of a biological response modifier (BRM) and an allergen is disclosed. In use the protein conjugate or mixture is combined with a pharmaceutically acceptable carrier. Cytokines, bacterial, fungal and viral immunopotentiators and thymus hormones are disclosed as suitable BRM's for use in the invention.
    Type: Grant
    Filed: June 7, 1990
    Date of Patent: May 26, 1992
    Assignee: Allergy Immuno Technologies, Inc.
    Inventor: Aristo Wojdani
  • Liposome containing immunotherapy agents for treating IgE mediated allergies
    Patent number: 5049390
    Abstract: An immunotherapy agent for the treatment of allergy composed of an allergen encapsulated in or covalently bound to a liposome is disclosed. Use of the agent in immunotherapy results in enhanced IgG production and reduced IgE production.
    Type: Grant
    Filed: April 25, 1990
    Date of Patent: September 17, 1991
    Assignee: Allergy Immuno Technologies, Inc.
    Inventor: Aristo Wojdani
  • Immunotherapy agents for treatment of IgE mediated allergies
    Patent number: 4946945
    Abstract: A protein conjugate or mixture useful in immunotherapy composed of a biological response modifier (BRM) and an allergen is disclosed. In use the protein conjugate or mixture is combined with a pharmaceutically acceptable carrier. Cytokines, bacterial, fungal and viral immunopotentiators and thymus hormones are disclosed as suitable BRM's for use in the invention.
    Type: Grant
    Filed: June 23, 1987
    Date of Patent: August 7, 1990
    Assignee: Allergy Immuno Technologies, Inc.
    Inventor: Aristo Wojdani